DPPC at Pharmex 2026: From Professional Meetings to a Visit by the Head of the Food and Drug Administration

The first day of the Pharmex Middle East 2026 International Exhibition was marked by a strong and active presence of DPPC, featuring a series of professional meetings and discussions with managers, experts, and key players across Iran’s pharmaceutical industry.

Throughout the day, the CEO, deputies, and senior managers of DPPC were present at the company’s booth, introducing the company’s capabilities, expertise, and activities while meeting with a range of managers and professionals across the pharmaceutical value chain. Discussions focused on potential areas for collaboration, development opportunities, and prospects for the future.

The CEO and a number of senior managers also visited various sections of the exhibition and the booths of pharmaceutical companies, gaining insight into the latest achievements, capabilities, and developments across the industry.

Visit by the Head of the Food and Drug Administration to TIPICO and DPPC

As part of the first day’s program, Dr. Pir-Salehi, Head of the Food and Drug Administration, visited the TIPICO and DPPC booth, where he met with company representatives and was briefed on the company’s capabilities, expertise, and activities.

Following the opening ceremony, Saeid Hajjari, CEO of DPPC and a member of the Board of Directors of the Pharmaceutical Raw Materials Syndicate, also joined the Head of the Food and Drug Administration, alongside other members of the Syndicate, in visiting different sections of the exhibition and the booths of pharmaceutical companies.

These visits provided an opportunity to discuss key issues and current challenges facing Iran’s pharmaceutical industry, explore existing capacities, and exchange views on ways to further develop and strengthen the industry.

Pharmex: A Platform for Industry Engagement and Collaboration

DPPC’s presence on the first day of Pharmex 2026 was accompanied by a series of professional meetings, constructive interactions, and discussions with managers and key players in the pharmaceutical industry. The presence provided an opportunity to strengthen professional relationships and lay the groundwork for new opportunities for collaboration throughout the remainder of the exhibition.

DPPC will continue its presence at Pharmex 2026, focusing on strengthening industry engagement, showcasing its capabilities, and creating new opportunities for collaboration, while welcoming pharmaceutical professionals and industry stakeholders throughout the exhibition.